Log In
person
Prometheus Biosciences Inc
RXDX
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Inflammatory Bowel Disease Pharma |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
6.81M | 100.00% |
| Inflammatory Bowel Disease Pharma |
Genetic, Genomic, and Sequencing Databases for Life Science Research
These companies provide genetic, genomic, and sequencing databases for life science research.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Inflammatory Bowel Disease Pharma
Pre-Revenue Pharmaceuticals
|
6.81M | 100.00% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Inflammatory Bowel Disease Pharma
Genetic, Genomic, and Sequencing Databases for Life Science Research
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies provide genetic, genomic, and sequencing databases for life science research.
|
||